Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-21Clinical Trial Update: A Clinical Trial of AAV2-BDNF Gene Therapy in Early Alzheimer's Disease and Mild Cognitive Impairment [Phase 1]
A Phase 1 clinical trial is recruiting to evaluate AAV2-BDNF gene therapy for early Alzheimer's disease and mild cognitive impairment.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Gene Therapy for APOE4 Homozygote of Alzheimer's Disease [Phase 1, Phase 2]
Update on a Phase 1/2 gene therapy trial for APOE4 homozygous Alzheimer's disease by Lexeo Therapeutics; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-20Clinical Trial Update: Stimulation to Improve Memory [NA]
A completed University of Michigan clinical trial evaluating stimulation to improve memory in individuals with Mild Cognitive Impairment and…
-
CLINICAL_TRIALS research · 2025-10-20Clinical Trial Update: In-Person Recruitment of Individuals to the Alzheimer's Prevention Trial (APT) Webstudy [NA]
The Alzheimer's Prevention Trial (APT) Webstudy is recruiting in-person participants, including individuals with memory decline and healthy …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease [Phase 2]
A Phase 2 study of ABBV-552 in mild Alzheimer's disease completed, assessing adverse events, changes in disease activity, and pharmacokineti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Feasiblity Study of Green Activity Program for People Living With Memory Challenges [NA]
A feasibility trial evaluating a Green Activity Program for people with memory challenges, including Mild Cognitive Impairment, Alzheimer's …
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type [Phase 3]
The long-term extension Phase 3 trial of AVP-786 for agitation in Alzheimer's-type dementia was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Person-Environment Fit for Persons With Dementia [NA]
The clinical trial on person-environment fit for people with Alzheimer's-related dementia has completed.
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) [Phase 1]
This Phase 1 trial update reports on the efficacy and safety of MK-1167 in participants with Alzheimer's disease dementia who are taking sta…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1 [NA]
Completed clinical trial evaluating a light exposure tracker designed to improve circadian rhythms in individuals with Alzheimer's disease a…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Supplementing Neuro-Energy to Aid Cognition [NA]
A clinical trial registry entry for a study evaluating Neuro-Energy supplementation to aid cognition in Alzheimer's disease and related deme…
-
CLINICAL_TRIALS trial_result · 2025-10-10Clinical Trial Update: Home-based Transcranial Direct Current Stimulation (tDCS) for Behavioral Symptoms in Alzheimer's Disease and Related Dementias (ADRD) [NA]
A completed clinical trial evaluated home-based transcranial direct current stimulation for behavioral symptoms in Alzheimer's disease and r…
-
CLINICAL_TRIALS trial_result · 2025-10-09Clinical Trial Update: The Revitalize Study in Older Adults at Risk for Alzheimer's Disease [Phase 2]
Phase 2 update on the Revitalize Study in older adults at risk for Alzheimer's disease, with results posted on 2025-10-09.
-
EMA approval · 2025-10-09EMA Authorised: Memantine Accord (memantine hydrochloride) — Accord Healthcare S.L.U.
EMA authorised Memantine Accord (memantine hydrochloride) for the treatment of Alzheimer’s disease. The product is marketed by Accord Health…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Vagus Nerve Stimulation to Enhance Memory in Aging [NA]
Clinical trial update on using vagus nerve stimulation to enhance memory in aging, sponsored by Stanford University; investigating Alzheimer…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease
A real-world comparative study is evaluating donanemab plus usual care versus usual care alone in US participants with early symptomatic Alz…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention [NA]
Clinical trial update indicates Brain Boosters 2, a digital application–supported intervention for people at risk for Alzheimer's disease, i…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab. [Phase 2]
This clinical trial update describes a Phase 2 study to evaluate the safety and tolerability of X/T+X-EC in participants with Alzheimer's di…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Optimizing Cognitive, Environmental, and Neuromotor Stimulation in Traumatic Brain Injury [NA]
A completed Johns Hopkins University clinical trial evaluated cognitive, environmental, and neuromotor stimulation for traumatic brain injur…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
This completed clinical trial examined how age influences amyloid load in typical Alzheimer's disease. It also studied amyloid deposition in…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Speech-Based Artificial Intelligence for Detection of Dementia in Danish Patients
Clinical trial update indicating that Zealand University Hospital is enrolling by invitation in a study using speech-based AI to detect deme…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study [Phase 1]
A Phase 1 clinical trial in Singapore is evaluating the safety of nucleoside reverse transcriptase inhibitors (NRTIs) for Alzheimer's diseas…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Biomarkers of Sleep-wake Cycle in Prodromal Alzheimer's Disease: Role in Cognitive Decline? [NA]
A clinical trial at University Hospital, Montpellier is investigating sleep-wake cycle biomarkers in prodromal Alzheimer's disease and their…
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Identification of Diagnosis Biomarkers in the Tears of Alzheimer's Disease Patients: The COG-EYE Pilot Study [NA]
Pilot study investigating tear-based biomarkers to aid diagnosis of Alzheimer's disease; currently recruiting at University Hospital, Tours.
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Brain Vascular and Neurocognitive Health [NA]
This clinical trial update reports the completion of a study focused on brain vascular health and neurocognitive outcomes, including Alzheim…